Posted in | News | Nanomaterials

Cal Nano Receives Large Order from Major Sports Shoe Manufacturer

California Nanotechnologies Corp ("Cal Nano" and "CNO") is pleased to announce the Company's largest order to date. These components will be utilized by adidas in their flagship commercial product line, the adiZero Prime SP track spike, which has become known worldwide as the lightest commercially available track and field shoe. This order is over three times the size of previous orders for this product and will generate revenue for the Company of over $89,000 US ($92,900 CAD).

"The Company has already produced the highly specialized material utilized in these products and plans on a partial delivery by the end of December 2013, as required to meet the customer's initial requirements," stated Christopher Melnyk, Vice President. "This order represents the successful transition from the developmental phase of this nanotechnology program into a higher volume commercial project."

California Nanotechnologies is also pleased to announce their attendance as exhibitors at the Materials Science and Technology ("MS&T") Conference in Montreal, Canada from October 27-30, 2013. Christopher Melnyk presented at the symposium on the topic "Benefits of Spark Plasma Sintering" to highlight the successful initiation of the Company's relationship with Fuji SPS of Japan. Cal Nano's presence at the MS&T'13 Conference generated significant interest among conference attendees, including several Fortune 100 companies and resulted in substantial leads for the various services offered by Cal Nano. The Company is working on solidifying those leads into new customers.

Press release avilable from http://www.prnewswire.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.